Policy | October 27, 2021
PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
It is the first presbyopia-correcting lens implant for cataract surgery
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
